Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

The role of mini-bronchoalveolar lavage fluid in the diagnosis of pulmonary tuberculosis in critically ill patients.

Neves CP, Costa AG, Safe IP, de Souza Brito A, Jesus JS, Kritski AL, Lacerda MVG, Viveiros M, Cordeiro-Santos M.

BMC Infect Dis. 2020 Mar 18;20(1):229. doi: 10.1186/s12879-020-04954-3.

2.

Spirometry results after treatment for pulmonary tuberculosis: comparison between patients with and without previous lung disease: a multicenter study.

Mancuzo EV, Martins Netto E, Sulmonett N, Viana VS, Croda J, Kritski AL, Mello FCQ, Nihues SSE, Azevedo KRS, Miranda SS.

J Bras Pneumol. 2020 Mar 2;46(2):e20180198. doi: 10.36416/1806-3756/e20180198. eCollection 2020. English, Portuguese.

3.

Serum anti-Mce1A immunoglobulin detection as a tool for differential diagnosis of tuberculosis and latent tuberculosis infection in children and adolescents.

Schmidt CM, Lovero KL, Carvalho FR, Dos Santos DCM, Barros ACMW, Quintanilha AP, Barbosa AP, Pone MVS, Pone SM, Araujo JM, de Paula Martins C, Macedo SGD, Miceli AL, Vieira ML, Sias SMA, Queiroz A, Coca Velarde LG, Kritski AL, Silva AA, Sant'Anna CC, Riley LW, Araújo Cardoso CA.

Tuberculosis (Edinb). 2020 Jan;120:101893. doi: 10.1016/j.tube.2019.101893. Epub 2019 Dec 5. No abstract available.

PMID:
32090854
4.

Genotype®MTBDRplus and Xpert®MTB/RIF in the diagnosis of tuberculosis and resistant tuberculosis: cost analysis in a tertiary referral hospital.

Soares VM, Almeida IN, Vater MC, Alves S, Figueredo LJA, Scherer L, Kritski AL, Carvalho WDS, Miranda SS.

Rev Soc Bras Med Trop. 2020 Feb 7;53:e20190175. doi: 10.1590/0037-8682-0175-2019. eCollection 2020.

5.

Polymorphisms in interferon pathway genes and risk of Mycobacterium tuberculosis infection in contacts of tuberculosis cases in Brazil.

Cubillos-Angulo JM, Arriaga MB, Melo MGM, Silva EC, Alvarado-Arnez LE, de Almeida AS, Moraes MO, Moreira ASR, Lapa E Silva JR, Fukutani KF, Sterling TR, Hawn TR, Kritski AL, Oliveira MM, Andrade BB.

Int J Infect Dis. 2020 Mar;92:21-28. doi: 10.1016/j.ijid.2019.12.013. Epub 2019 Dec 13.

6.

First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.

Salvato RS, Costa ERD, Reis AJ, Schiefelbein SH, Halon ML, Barcellos RB, Unis G, Dias CF, Viveiros M, Portugal I, da Silva PEA, Kritski AL, Perdigão J, Rossetti MLR.

Infect Genet Evol. 2020 Mar;78:104127. doi: 10.1016/j.meegid.2019.104127. Epub 2019 Nov 26.

PMID:
31783187
7.

Relationship of anti-tuberculosis drug-induced liver injury and genetic polymorphisms in CYP2E1 and GST.

Santos EA, Gonçalves JCS, Fleury MK, Kritski AL, Oliveira MM, Velasque LS, E Silva JRL, Estrela RCE.

Braz J Infect Dis. 2019 Nov - Dec;23(6):381-387. doi: 10.1016/j.bjid.2019.09.003. Epub 2019 Nov 4.

8.

Contribution of Xpert MTB/RIF to clinical diagnosis in adolescents with tuberculosis in Rio de Janeiro, Brazil.

Oliveira MCB, Sant'Anna CC, Luiz RR, Soares ECC, Kritski AL.

Int J Tuberc Lung Dis. 2019 Oct 1;23(10):1115-1121. doi: 10.5588/ijtld.18.0778.

PMID:
31627777
9.

Molecular characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from a high-burden tuberculosis state in Brazil.

Salvato RS, Schiefelbein S, Barcellos RB, Praetzel BM, Anusca IS, Esteves LS, Halon ML, Unis G, Dias CF, Miranda SS, de Almeida IN, de Assis Figueredo LJ, Silva EC, Kritski AL, Dalla Costa ER, Rossetti MLR.

Epidemiol Infect. 2019 Jan;147:e216. doi: 10.1017/S0950268819001006.

10.

Imbalance of NET and Alpha-1-Antitrypsin in Tuberculosis Patients Is Related With Hyper Inflammation and Severe Lung Tissue Damage.

de Melo MGM, Mesquita EDD, Oliveira MM, da Silva-Monteiro C, Silveira AKA, Malaquias TS, Dutra TCP, Galliez RM, Kritski AL, Silva EC; Rede-TB Study Group.

Front Immunol. 2019 Jan 10;9:3147. doi: 10.3389/fimmu.2018.03147. eCollection 2018.

11.

Polymorphisms in TLR4 and TNFA and Risk of Mycobacterium tuberculosis Infection and Development of Active Disease in Contacts of Tuberculosis Cases in Brazil: A Prospective Cohort Study.

Cubillos-Angulo JM, Arriaga MB, Silva EC, Müller BLA, Ramalho DMP, Fukutani KF, Miranda PFC, Moreira ASR, Ruffino-Netto A, Lapa E Silva JR, Sterling TR, Kritski AL, Oliveira MM, Andrade BB.

Clin Infect Dis. 2019 Aug 30;69(6):1027-1035. doi: 10.1093/cid/ciy1001.

12.

Prevalence of depression among patients with presumptive pulmonary tuberculosis in Rio de Janeiro, Brazil.

Castro-Silva KM, Carvalho AC, Cavalcanti MT, Martins PDS, França JR, Oquendo M, Kritski AL, Sweetland A.

Braz J Psychiatry. 2019 Jul-Aug;41(4):316-323. doi: 10.1590/1516-4446-2018-0076. Epub 2018 Oct 22.

13.

Screening for active pulmonary tuberculosis: Development and applicability of artificial neural network models.

Souza Filho JBOE, Sanchez M, Seixas JM, Maidantchik C, Galliez R, Moreira ADSR, da Costa PA, Oliveira MM, Harries AD, Kritski AL.

Tuberculosis (Edinb). 2018 Jul;111:94-101. doi: 10.1016/j.tube.2018.05.012. Epub 2018 May 19.

PMID:
30029922
14.

Sequential analysis as a tool for detection of amikacin ototoxicity in the treatment of multidrug-resistant tuberculosis.

Vasconcelos KA, Frota SMMC, Ruffino-Netto A, Kritski AL.

J Bras Pneumol. 2018 Apr;44(2):85-92. doi: 10.1590/s1806-37562016000000312. Portuguese, English.

15.

Predictors of mortality among intensive care unit patients coinfected with tuberculosis and HIV.

Ferreira MD, Neves CPD, Souza AB, Beraldi-Magalhães F, Migliori GB, Kritski AL, Cordeiro-Santos M.

J Bras Pneumol. 2018 Apr;44(2):118-124. doi: 10.1590/s1806-37562017000000316. Portuguese, English.

16.

The importance of audiometric monitoring in patients with multidrug-resistant tuberculosis.

Vasconcelos KA, Frota SMMC, Ruffino-Netto A, Kritski AL.

Rev Soc Bras Med Trop. 2017 Sep-Oct;50(5):646-651. doi: 10.1590/0037-8682-0465-2016.

17.

Evaluation of the Commercial Kit SIRE Nitratase for detecting resistant Mycobacterium tuberculosis in Brazil.

Miranda SS, Almeida IN, Lopes ML, Figueiredo JDR, Figueredo LJA, Kritski AL, Carvalho WDS, Mansur MFFO.

Rev Soc Bras Med Trop. 2017 Jul-Aug;50(4):550-553. doi: 10.1590/0037-8682-0447-2016.

18.

Outcomes from patients with presumed drug resistant tuberculosis in five reference centers in Brazil.

Ramalho DMP, Miranda PFC, Andrade MK, Brígido T, Dalcolmo MP, Mesquita E, Dias CF, Gambirasio AN, Ueleres Braga J, Detjen A, Phillips PPJ, Langley I, Fujiwara PI, Squire SB, Oliveira MM, Kritski AL; for Rede-TB Study group.

BMC Infect Dis. 2017 Aug 15;17(1):571. doi: 10.1186/s12879-017-2669-1.

19.

Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru.

Calderón RI, Velásquez GE, Becerra MC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Kritski AL, Murray MB, Mitnick CD.

Int J Tuberc Lung Dis. 2017 Aug 1;21(8):894-901. doi: 10.5588/ijtld.16.0850.

20.

A comparison of tuberculosis diagnostic systems in a retrospective cohort of HIV-infected children in Rio de Janeiro, Brazil.

David SG, Lovero KL, Pombo March MFB, Abreu TG, Ruffino Netto A, Kritski AL, Sant'Anna CC; Rede-TB Study Group.

Int J Infect Dis. 2017 Jun;59:150-155. doi: 10.1016/j.ijid.2017.01.038. Epub 2017 Apr 25.

21.

Correction: Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice.

Almeida FM, Ventura TL, Amaral EP, Ribeiro SC, Calixto SD, Manhães MR, Rezende AL, Souza GS, de Carvalho IS, Silva EC, da Silva JA, Carvalho EC, Kritski AL, Lasunskaia EB.

PLoS One. 2017 Apr 6;12(4):e0175652. doi: 10.1371/journal.pone.0175652. eCollection 2017.

22.

Hypervirulent Mycobacterium tuberculosis strain triggers necrotic lung pathology associated with enhanced recruitment of neutrophils in resistant C57BL/6 mice.

Almeida FM, Ventura TL, Amaral EP, Ribeiro SC, Calixto SD, Manhães MR, Rezende AL, Souza GS, de Carvalho IS, Silva EC, Silva JA, Carvalho EC, Kritski AL, Lasunskaia EB.

PLoS One. 2017 Mar 17;12(3):e0173715. doi: 10.1371/journal.pone.0173715. eCollection 2017. Erratum in: PLoS One. 2017 Apr 6;12 (4):e0175652. Souzal GS [corrected to Souza GS].

23.

Evaluation of the Mean Cost and Activity Based Cost in the Diagnosis of Pulmonary Tuberculosis in the Laboratory Routine of a High-Complexity Hospital in Brazil.

de Almeida IN, de Assis Figueredo LJ, Soares VM, Vater MC, Alves S, da Silva Carvalho W, Kritski AL, de Miranda SS.

Front Microbiol. 2017 Feb 15;8:249. doi: 10.3389/fmicb.2017.00249. eCollection 2017.

24.

Performance of a molecular assay to detect Mycobacterium tuberculosis complex DNA in clinical specimens: multicenter study in Brazil.

Verza M, Schmid KB, Barcellos RB, Linck N, Bello GL, Scapin D, Sperhacke RD, Silva MS, Wollheim C, Rivero MG, Kritski AL, Rezende L Jr, Oliveira MM, Costa ER, Rossetti ML.

Mem Inst Oswaldo Cruz. 2017 Feb;112(2):94-99. doi: 10.1590/0074-02760160196.

25.

Transcriptomic Biomarkers for Tuberculosis: Evaluation of DOCK9. EPHA4, and NPC2 mRNA Expression in Peripheral Blood.

de Araujo LS, Vaas LA, Ribeiro-Alves M, Geffers R, Mello FC, de Almeida AS, Moreira AD, Kritski AL, Lapa E Silva JR, Moraes MO, Pessler F, Saad MH.

Front Microbiol. 2016 Oct 25;7:1586. eCollection 2016.

26.

Prevalence of latent Mycobacterium tuberculosis infection in prisoners.

Navarro PD, Almeida IN, Kritski AL, Ceccato MD, Maciel MM, Carvalho WD, Miranda SS.

J Bras Pneumol. 2016 Sep-Oct;42(5):348-355. doi: 10.1590/S1806-37562016000000001. English, Portuguese.

27.

Development of two artificial neural network models to support the diagnosis of pulmonary tuberculosis in hospitalized patients in Rio de Janeiro, Brazil.

Aguiar FS, Torres RC, Pinto JV, Kritski AL, Seixas JM, Mello FC.

Med Biol Eng Comput. 2016 Nov;54(11):1751-1759. Epub 2016 Mar 25.

PMID:
27016365
28.

Tuberculosis incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.

Grassi MF, Dos Santos NP, Lírio M, Kritski AL, Chagas Almeida Mda C, Santana LP, Lázaro N, Dias J, Netto EM, Galvão-Castro B.

BMC Infect Dis. 2016 Sep 19;16:491. doi: 10.1186/s12879-016-1428-z.

29.

Clinical Features and Treatment Outcomes of Patients with Drug-Resistant and Drug-Sensitive Tuberculosis: A Historical Cohort Study in Porto Alegre, Brazil.

Micheletti VC, Kritski AL, Braga JU.

PLoS One. 2016 Aug 9;11(8):e0160109. doi: 10.1371/journal.pone.0160109. eCollection 2016.

30.

Latent Tuberculosis Infection Diagnostic and Treatment Cascade among Contacts in Primary Health Care in a City of Sao Paulo State, Brazil: Cross-Sectional Study.

Wysocki AD, Villa TC, Arakawa T, Brunello ME, Vendramini SH, Monroe AA, Kritski AL.

PLoS One. 2016 Jun 10;11(6):e0155348. doi: 10.1371/journal.pone.0155348. eCollection 2016.

31.

A screening system for smear-negative pulmonary tuberculosis using artificial neural networks.

de O Souza Filho JB, de Seixas JM, Galliez R, de Bragança Pereira B, de Q Mello FC, Dos Santos AM, Kritski AL.

Int J Infect Dis. 2016 Aug;49:33-9. doi: 10.1016/j.ijid.2016.05.019. Epub 2016 May 24.

32.

Abandonment of Treatment for Latent Tuberculosis Infection and Socioeconomic Factors in Children and Adolescents: Rio De Janeiro, Brazil.

Mendonça AM, Kritski AL, Land MG, Sant'Anna CC.

PLoS One. 2016 May 5;11(5):e0154843. doi: 10.1371/journal.pone.0154843. eCollection 2016.

33.

Liquid vs Solid Culture Medium to Evaluate Proportion and Time to Change in Management of Suspects of Tuberculosis-A Pragmatic Randomized Trial in Secondary and Tertiary Health Care Units in Brazil.

Moreira Ada S, Huf G, Vieira MA, Costa PA, Aguiar F, Marsico AG, Fonseca Lde S, Ricks M, Oliveira MM, Detjen A, Fujiwara PI, Squire SB, Kritski AL.

PLoS One. 2015 Jun 5;10(6):e0127588. doi: 10.1371/journal.pone.0127588. eCollection 2015.

34.

Genetic diversity of the Mycobacterium tuberculosis Beijing family in Brazil and Mozambique and relation with infectivity and induction of necrosis in THP-1 cells.

Gomes LL, Vasconcellos SE, Gomes HM, Elias AR, da Silva Rocha A, Ribeiro SC, Panunto AC, Ferrazoli L, da Silva Telles MA, Ivens de AM, Kritski AL, Mokrousov I, Manicheva OA, Lasunskaia E, Suffys PN.

Tuberculosis (Edinb). 2015 Jun;95 Suppl 1:S190-6. doi: 10.1016/j.tube.2015.02.025. Epub 2015 Feb 25.

PMID:
25841343
35.

Tuberculosis contact tracing among children and adolescent referred to children's hospital in Rio de Janeiro, Brazil.

Mendonça AM, Kritski AL, Sant'Anna CC.

Braz J Infect Dis. 2015 May-Jun;19(3):296-301. doi: 10.1016/j.bjid.2014.12.005. Epub 2015 Jan 27.

36.

Anemia in hospitalized patients with pulmonary tuberculosis.

Oliveira MG, Delogo KN, Oliveira HM, Ruffino-Netto A, Kritski AL, Oliveira MM.

J Bras Pneumol. 2014 Jul-Aug;40(4):403-10. English, Portuguese.

38.

Association between serum selenium level and conversion of bacteriological tests during antituberculosis treatment.

Moraes ML, Ramalho DM, Delogo KN, Miranda PF, Mesquita ED, Oliveira HM, Ruffino-Netto A, Almeida PC, Hauser-Davis RA, Campos RC, Kritski AL, Oliveira MM.

J Bras Pneumol. 2014 May-Jun;40(3):269-78. English, Portuguese.

39.

Association of serum levels of iron, copper, and zinc, and inflammatory markers with bacteriological sputum conversion during tuberculosis treatment.

Moraes ML, Ramalho DM, Delogo KN, Miranda PF, Mesquita ED, de Melo Guedes de Oliveira HM, Netto AR, Dos Anjos MJ, Kritski AL, de Oliveira MM.

Biol Trace Elem Res. 2014 Aug;160(2):176-84. doi: 10.1007/s12011-014-0046-0. Epub 2014 Jun 24.

PMID:
24958018
40.

Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil.

Micheletti VC, Moreira Jda S, Ribeiro MO, Kritski AL, Braga JU.

J Bras Pneumol. 2014 Mar-Apr;40(2):155-63. English, Portuguese.

41.

In house reverse membrane hybridisation assay versus GenoType MTBDRplus and their performance to detect mutations in the genes rpoB, katG and inhA.

Ferreira Junior SL, Dalla Costa ER, Santos PG, Gomes HM, Silva MS, Esteves LS, Oliveira MM, Maschmann Rde A, Kritski AL, Suffys PN, Rossetti ML.

Mem Inst Oswaldo Cruz. 2014 Jun;109(3):307-14. Epub 2014 May 7.

42.

Inflammatory and immunogenetic markers in correlation with pulmonary tuberculosis.

Muller BL, Ramalho DM, Santos PF, Mesquita ED, Kritski AL, Oliveira MM.

J Bras Pneumol. 2013 Nov-Dec;39(6):719-27. doi: 10.1590/S1806-37132013000600011. English, Portuguese.

43.
44.

Completeness of tuberculosis reporting forms in five Brazilian capitals with a high incidence of the disease.

Santos NP, Lírio M, Passos LA, Dias JP, Kritski AL, Galvão-Castro B, Grassi MF.

J Bras Pneumol. 2013 Mar-Apr;39(2):221-5. English, Portuguese.

45.

Safety and effectiveness of HAART in tuberculosis-HIV co-infected patients in Brazil.

dos Santos AP, Pacheco AG, Staviack A, Golub JE, Chaisson RE, Rolla VC, Kritski AL, Passos SR, de Queiroz Mello FC.

Int J Tuberc Lung Dis. 2013 Feb;17(2):192-7. doi: 10.5588/ijtld.11.0831.

46.

Factors associated with pulmonary tuberculosis among patients seeking medical attention at referral clinics for tuberculosis.

Alcântara CC, Kritski AL, Ferreira VG, Façanha MC, Pontes RS, Mota RS, Leitão Tdo M.

J Bras Pneumol. 2012 Sep-Oct;38(5):622-9. English, Portuguese.

47.

Epidemiological aspects of tuberculosis in children and adolescents in Rio de Janeiro.

Matos TP, Kritski AL, Ruffino Netto A.

J Pediatr (Rio J). 2012 Jul;88(4):335-40. doi: 10.2223/JPED.2207.

48.

Classification and regression tree (CART) model to predict pulmonary tuberculosis in hospitalized patients.

Aguiar FS, Almeida LL, Ruffino-Netto A, Kritski AL, Mello FC, Werneck GL.

BMC Pulm Med. 2012 Aug 7;12:40. doi: 10.1186/1471-2466-12-40.

49.

Tuberculosis caused by RDRio Mycobacterium tuberculosis is not associated with differential clinical features.

Barbosa Cde B, Lazzarini LC, Elias AR, Leung JA, Ribeiro SB, da Silva MG, Duarte RS, Suffys P, Gomes HM, Kritski AL, Lapa E Silva JR, Ho JL, Boéchat N.

Int J Tuberc Lung Dis. 2012 Oct;16(10):1377-82. doi: 10.5588/ijtld.11.0709. Epub 2012 Aug 3.

50.

Interleukin-10 and interferon-gamma patterns during tuberculosis treatment: possible association with recurrence.

Lago PM, Boéchat N, Migueis DP, Almeida AS, Lazzarini LC, Saldanha MM, Kritski AL, Ho JL, Lapa e Silva JR.

Int J Tuberc Lung Dis. 2012 May;16(5):656-9. doi: 10.5588/ijtld.11.0707. Epub 2012 Mar 8.

Supplemental Content

Loading ...
Support Center